The Treatment of Older Patients With Multiple Myeloma
C. Ola Landgren, MD, PhD, a senior investigator in the Multiple Myeloma Section of the National Cancer Institute, discusses the treatment of older patients (over age 70) with multiple myeloma.
C. Ola Landgren, MD, PhD, a senior investigator in the Multiple Myeloma Section of the National Cancer Institute, discusses the treatment of older patients (over age 70) with multiple myeloma. This interview took place at the 2013 American Society of Hematology (ASH) Meeting.
Clinical Pearls
-Every year in the U.S., 10,000 people under the age of 70 and 10,000 people over the age of 70 are diagnosed with multiple myeloma
-Younger patients typically experience better outcomes while older patients do not see much improvement
@TargetedOncUsing newer therapy strategies, my projection is that#MultipleMyelomapts 70+ yrs will have 2-3x better survival within 5 yrs
Ola Landgren, M.D. (@DrOlaLandgren)April 9, 2014
-Now that older patients are being treated with new drugs, they​ are seeing an improvement in survival
Fellow's Perspective: Impact of Quadruplet and MRD in Newly Diagnosed Multiple Myeloma
December 17th 2024In a discussion with Peers & Perspectives in Oncology, fellowship program director Marc J. Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about how recent trials shape their approach for a patient with transplant-eligible multiple myeloma.
Read More
